Rituximab is used alone or with other drugs to treat non-Hodgkin's lymphoma, chronic lymphocytic leukaemia and rheumatoid arthritis.
Indian Pharmaceutical Company Soon to Register for a New Drug With USFDA
Sun Pharma company has now three products undergoing clinical trials and will hopefully register them in the next two to three years.
Sun Pharma company has now three products undergoing clinical trials and will hopefully register them in the next two to three years.
"Biosimilars is one of the key strategic business areas for Hetero. We have invested in biosimilars and will introduce more biosimilar MAB's in the future. We also have plans to introduce affordable biosimilar Rituximab into key markets outside India through our partners," he added.
"Rituximab is used alone or with other drugs to treat non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. It is also used for the treatment of other indications such as rheumatoid arthritis," said Hetero.
Pivotal Expansion: Lupin Pharmaceuticals Acquires US-Based Gavis for $880 Million
In a pivotal move to expand their global presence, an Indian Pharmaceutical company- Lupin Pharmaceuticals, acquired Gavis, a US- based privately- held company.
In a pivotal move to expand their global presence, an Indian Pharmaceutical company- Lupin Pharmaceuticals, acquired Gavis, a US- based privately- held company.
US-Based Pharmaceutical Company Issues Voluntary Recall Of Hypertension Drugs
Hydrochlorothiazide Tablets 25 mg 1000-count bottle was contaminated with another tablet, which could cause bleeding and bruising if a patient takes it unknowingly.
Hydrochlorothiazide Tablets 25 mg 1000-count bottle was contaminated with another tablet, which could cause bleeding and bruising if a patient takes it unknowingly.
GlaxoSmithKline Pharmaceuticals Facility in Bengaluru to be Operational by 2017
The new unit plans to rationalize, streamline and reduce medicine costs and increase capacity to meet the growing demands for important medicines.
The new unit plans to rationalize, streamline and reduce medicine costs and increase capacity to meet the growing demands for important medicines.
